REYATAZ

Product NDC

50090-1581

11-digit product format

500901581

Labeler code

50090

Product ID

50090-1581_07a92e16-603b-4208-88e9-ed3399a3c3e6

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

ATAZANAVIR

Dosage form

CAPSULE, GELATIN COATED

Route

ORAL

Labeler

A-S Medication Solutions

Application

NDA021567

Marketing category

NDA

Marketing start

2003-06-24

Marketing end

0000-00-00

Substance

ATAZANAVIR SULFATE

Active strength

200 mg/1

Pharmacologic classes

HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]

NDC exclude flag

No

Listing certified through

2019-12-31

Current FDA listing

Historical FDA.report record